Scarica l'app Stockscreener
12.49
4.00%
0.48
Dopo l'orario di chiusura:
12.49
Replimune Group Inc Borsa (REPL) Ultime notizie
Replimune Group (NASDAQ:REPL) Stock Price Up 8.2%Here's Why - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 6,759 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Insider Selling: Replimune Group, Inc. (NASDAQ:REPL) CEO Sells 10,000 Shares of Stock - MarketBeat
Replimune CEO Sushil Patel sells $124,200 in company stock - Investing.com
Replimune CEO Sushil Patel sells $124,200 in company stock By Investing.com - Investing.com UK
Wellington Management Group LLP Decreases Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
BNP Paribas Financial Markets Buys 6,748 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Trading Down 4.7%Here's Why - MarketBeat
When (REPL) Moves Investors should Listen - Stock Traders Daily
Replimune's SWOT analysis: biotech's melanoma treatment stock nears key milestones By Investing.com - Investing.com South Africa
Replimune's SWOT analysis: biotech's melanoma treatment stock nears key milestones - Investing.com India
Replimune Group, Inc. (NASDAQ:REPL) Short Interest Down 16.5% in November - MarketBeat
Fmr LLC Sells 120,776 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Fmr LLC Has $6.87 Million Position in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Charles Schwab Investment Management Inc. Buys 52,498 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Charles Schwab Investment Management Inc. Purchases 52,498 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Jacobs Levy Equity Management Inc. Sells 44,153 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
The Manufacturers Life Insurance Company Increases Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Receives $17.29 Average PT from Analysts - MarketBeat
Intech Investment Management LLC Buys New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Where are the Opportunities in (REPL) - Stock Traders Daily
Replimune Group, Inc. (NASDAQ:REPL) Holdings Reduced by Redmile Group LLC - MarketBeat
Parkman Healthcare Partners LLC Buys 238,747 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune stock target raised to $19 on BLA submission By Investing.com - Investing.com Canada
Baker BROS. Advisors LP Has $121.06 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Algert Global LLC - MarketBeat
Braidwell LP Acquires 2,057,460 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Replimune Group Announces Pricing of Public Offering - Defense World
Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch - Seeking Alpha
Replimune Group Amends Sales Agreement with Leerink Partners LLC - Defense World
Replimune reduces offering size in amended sales agreement - Investing.com
Replimune reduces offering size in amended sales agreement By Investing.com - Investing.com Australia
SEC Form 424B5 filed by Replimune Group Inc. - Quantisnow
Cancer firm Replimune readies $125 million offering - The Pharma Letter
REPLReplimune Group, Inc. Latest Stock News & Market Updates - StockTitan
Replimune announces $125 million public offering By Investing.com - Investing.com South Africa
Replimune's SWOT analysis: stock outlook as RP1 nears key milestones By Investing.com - Investing.com Canada
Replimune Announces Pricing of Upsized Public Offering - The Manila Times
Replimune Prices $140M Upsized Public Offering of Common Stock & Warrants | REPL Stock News - StockTitan
Replimune's SWOT analysis: stock outlook as RP1 nears key milestones - Investing.com
How to Take Advantage of moves in (REPL) - Stock Traders Daily
Replimune announces $125 million public offering - Investing.com India
Replimune Announces Proposed Public Offering - The Manila Times
Canadian Dollar/Japanese Yen (CADJPY) QuotePress Release - The Globe and Mail
Replimune Group (NASDAQ:REPL) Price Target Raised to $18.00 - Defense World
Replimune Group (NASDAQ:REPL) Earns Buy Rating from HC Wainwright - Defense World
Replimune's stock surges 19% after-hours on FDA BLA submission - MSN
Replimune Group (NASDAQ:REPL) Reaches New 52-Week High on Analyst Upgrade - MarketBeat
BMO Capital Markets Increases Replimune Group (NASDAQ:REPL) Price Target to $18.00 - MarketBeat
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry? - Simply Wall St
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):